arginine vasopressin has been researched along with Diabetes Insipidus, Neurogenic in 106 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (33.02) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 31 (29.25) | 29.6817 |
2010's | 27 (25.47) | 24.3611 |
2020's | 13 (12.26) | 2.80 |
Authors | Studies |
---|---|
Ishizuka, Y; Maegawa, H; Nakamura, T; Sugawara, L | 1 |
Che, M; Feng, Z; Gong, H; Li, K; Liu, Y; Niu, P; Ou, Y; Peng, J; Qi, S; Wang, X; Wu, G; Zhou, M | 1 |
Lawless, S; Martin-Grace, J; Sherlock, M; Thompson, CJ; Tomkins, M | 1 |
Ando, F; Arima, H; Banno, R; Hagiwara, D; Hodai, Y; Iwama, S; Katsuki, T; Kawaguchi, Y; Kobayashi, T; Kurimoto, J; Miyata, T; Onoue, T; Suga, H; Sugiyama, M; Takagi, H; Tsumura, T; Uchida, S; Yasuda, Y | 1 |
Avila-Blanco, ME; Calvillo-Robedo, A; González-Blas, D; Muñoz-Ortega, MH; Navarro-Gonzalez, YD; Quintanar-Stephano, A; Valdez-Urias, F; Ventura-Juarez, J | 1 |
Arima, H; Azuma, Y; Hagiwara, D; Kawaguchi, Y; Miyata, T | 1 |
Moodley, N | 1 |
Newell-Price, J | 1 |
Arima, H; Banno, R; Goto, M; Hagiwara, D; Handa, T; Ito, Y; Iwama, S; Matsui, S; Onoue, T; Suga, H; Sugiyama, M; Takagi, H; Takahashi, K; Tsunekawa, T | 1 |
Deligiorgi, MV; Siasos, G; Trafalis, DT; Vergadis, C | 1 |
Alvelos, MI; Carreiro, S; Francisco, Â; Gama-de-Sousa, S; Gomes, L; Gonçalves, I; Lemos, MC; Marques, P; Melo, M; Paiva, I; Quintela, T | 1 |
Cardona, Z; Eisenberg, Y; Kothari, V | 1 |
Cantara, S; Capezzone, M; Castagna, MG; Marzocchi, C; Sagnella, A | 1 |
Aagaard, L; Christensen, JH; Corydon, TJ; Gregersen, N; Kvistgaard, H; Luo, Y; Rittig, S; Toustrup, LB; Zhou, Y | 1 |
Bao, Y; Feng, Z; Ma, L; Ou, Y; Qi, S; Qiu, B; Wu, G; Zhou, M | 1 |
Arima, H; Azuma, Y; Banno, R; Goto, M; Hagiwara, D; Ito, Y; Iwama, S; Miyata, T; Morishita, Y; Onoue, T; Suga, H; Takagi, H; Tochiya, M; Tsunekawa, T | 1 |
Garrahy, A; Moran, C; Thompson, CJ | 1 |
Feng, ZP; Gong, HD; Li, K; Liu, YW; Ou, YC; Peng, JJ; Qi, ST; Qiu, BH; Wang, YJ; Zhou, MF | 1 |
Imamura, H; Konomoto, T; Nunoi, H; Orita, M; Sawada, H; Tanaka, E | 1 |
Arima, H; Asai, N; Azuma, Y; Banno, R; Goto, M; Hagiwara, D; Ito, Y; Morishita, Y; Oiso, Y; Shiota, A; Suga, H; Sugimura, Y; Takahashi, M; Wenjun, L | 1 |
Arima, H; Asai, N; Azuma, Y; Banno, R; Goto, M; Hagiwara, D; Lu, W; Mori, K; Morishita, Y; Oiso, Y; Oyadomari, S; Shiota, A; Suga, H; Sugimura, Y; Takahashi, M | 1 |
Aitella, E; Barrasso, M; Bellastella, G; Bizzarro, A; Cozzolino, D; De Bellis, A; Di Martino, S; Esposito, K | 1 |
Allolio, B; Arici, B; Christ-Crain, M; Fenske, W; Frech, N; Katan, M; Kopp, P; Kühn, F; Müller, B; Rutishauser, J; Stettler, C; Timper, K | 1 |
Cuesta, M; Dineen, R; Gupta, S; Hannon, MJ; Salehmohamed, R; Thompson, CJ; Tormey, W | 1 |
Copeland, CC; Hong, JC; Ramos, E; Ziv, K | 1 |
Cen, J; Gu, F; Nie, M; Tian, D | 1 |
Čižmárová, M; Dallos, T; Hána, V; Hrčková, G; Jankó, V; Košťálová, Ľ; Kovács, L; Kytnarová, J; Lebl, J; Tesařová, M; Virgová, D; Zeman, J | 1 |
Bachmann, S; Blottner, D; Böhlick, A; Gamba, G; Kahl, T; Mutig, K; Ponce-Coria, J; Salanova, M; Schlüter, H; Welker, P | 1 |
Wiwanitkit, V | 1 |
Brito, VN; Knoepfelmacher, M; Mancini, MC; Marui, S; Melo, ME; Mendonca, BB | 1 |
Arima, H; Hayashi, M; Hiroi, M; Kinoshita, N; Morishita, Y; Nagasaki, H; Oiso, Y; Ozaki, N; Shiota, A; Ueda, M | 1 |
Abdulhadi-Atwan, M; Abu Libdeh, A; Bosin, E; Korner, M; Levy-Khademi, F; White, PC; Zangen, DH | 1 |
Arima, H; Oiso, Y | 1 |
Komatsu, M; Nishio, S; Sato, A; Uehara, T; Yamazaki, M | 1 |
Dou, J; Guo, Q; Lu, J; Mu, Y; Pan, C | 1 |
de Fost, M; Endert, E; Fliers, E; Kamsteeg, EJ; Swaab, DF; van den Elzen, C; van Santen, HM; van Trotsenburg, AS | 1 |
Babey, M; Kopp, P; Robertson, GL | 1 |
Arima, H; Asai, N; Hagiwara, D; Hayashi, M; Hiroi, M; Morishita, Y; Nagasaki, H; Oiso, Y; Ozaki, N; Shiota, A; Sugimura, Y; Takahashi, M | 1 |
Latcha, S; Lubetzky, M; Weinstein, AM | 1 |
Jin, C; Luo, Y; Ma, X; Qiu, Y; Wang, B; Zhang, C; Zhao, Y; Zhu, Q | 1 |
Gabbi, C; Gao, M; Guan, Y; Gustafsson, JÅ; Jia, X; Kim, HJ; Kong, X; Ohnishi, H; Suzuki, H; Ueta, Y; Warner, M | 1 |
Bichet, DG | 1 |
Christensen, JH; Gregersen, N; Jendle, J; Kvistgaard, H; Rittig, S | 1 |
Dong, F; Li, C; Liu, Y; Lu, W; Lu, X; Ye, D; Zhang, Z | 1 |
Kanemitsu, N; Kawauchi, A; Miki, T; Mizutani, Y; Nishida, M; Shirahama, S; Tanaka, Y | 1 |
Boson, WL; d'Alva, CB; De Marco, L; Faria, D; Friedman, E; Sarubi, JC; Wajchenberg, B | 1 |
Altucci, P; Bellastella, A; Bizzarro, A; Colao, A; De Bellis, A; Di Salle, F; Di Somma, C; Faggiano, A; Lombardi, G; Perrino, S; Petretta, M; Pivonello, R | 1 |
Bienemann, AS; Cosgrave, AS; Glover, CP; Kingsman, SM; Martin-Rendon, E; Mazarakis, ND; Mitrophanous, KA; Uney, JB; Wong, LF | 1 |
Christensen, JH; Rittig, S; Siggaard, C | 1 |
Dötsch, J; Holder, M; Metzler, M; Rascher, W; Repp, R; Wolf, MT | 1 |
SCHAACK, G | 1 |
KLEIN, R; LARON, Z | 1 |
SMITH, WW | 1 |
HANKISS, J | 4 |
BELLENS, R; LOEB, H; VAN GEFFEL, R; WATTIEZ, R | 1 |
BASTENIE, PA; BELLENS, R; CONARD, V; DEMANET, JC | 1 |
HANKIS, J | 1 |
BALAZ, V; SPANAR, E | 1 |
KAPLAN, SA; STRAUSS, J; YUCEOGLU, AM | 1 |
EGLIN, JM; JESSIMAN, AG | 1 |
CARRE, IJ; McCOY, JE | 1 |
CZACZKES, JW; ELIAKIM, M; ULLMANN, TD | 1 |
ALEXANDER, CS; FILBIN, DM; FRUCHTMAN, SA | 1 |
DEL GRECO, F | 1 |
KLVANOVA, H; NEUBAUER, E; POR, F | 1 |
FRIEDMAN, CL; FRIEDMAN, SM; NAKASHIMA, M; SRETER, FA | 1 |
VESTERMARK, S | 1 |
YAMADA, R; YOSHITOSHI, Y | 1 |
COHEN, AL | 1 |
DELZANT, G | 1 |
FABRICANT, ND | 1 |
CINOTTI, GA | 1 |
MOSES, A | 1 |
CHIRMAN, SB; KINSELL, LW | 1 |
FANTATO, S | 1 |
DASCALU, R; GOZARIU, L | 1 |
EISENBERG, E | 1 |
BRODEHL, J; GELLISSEN, K; HAGGE, W | 1 |
MOEHLIG, RC; SCHULTZ, RC | 1 |
BELLENS, R; LOEB, H; WATTIEZ, R | 1 |
ORLIKOWSKA, W | 1 |
RODECK, H | 1 |
Phillips, JA | 1 |
Ito, M; Jameson, JL; Martinson, FA; Russell, TA; Weiss, J; Yu, RN | 1 |
Hanazono, Y; Honda, K; Ideno, J; Ishibashi, S; Kume, A; Mizukami, H; Okada, T; Ozawa, K; Saito, T | 1 |
Christensen, JH; Corydon, TJ; deSanctis, L; Gregersen, N; Kovacs, L; Rittig, S; Robertson, GL; Siggaard, C | 1 |
Bolund, L; Christensen, JH; Corydon, TJ; Gregersen, N; Rittig, S; Robertson, GL; Siggaard, C | 2 |
Baglioni, S; Corona, G; Maggi, M; Peri, A; Serio, M | 1 |
Bohn, D; Davids, MR; Friedman, O; Halperin, ML | 1 |
Bolund, L; Christensen, JH; Corydon, TJ; Gregersen, N; Pedersen, EB; Rittig, S; Robertson, GL; Siggaard, C | 1 |
Abbes, AP; Davies, JH; Engel, H; Gregory, JW; Penney, M | 1 |
Fujisawa, I; Ikeda, K; Ishihara, T; Iwakura, T; Kasahara, M; Kobayashi, H; Ogawa, Y; Son, C; Yoshimoto, A | 1 |
Ishikawa, SE | 1 |
Ambrosini, L; Bellastella, A; De Amici, M; De Bellis, A; di Iorgi, N; Ghirardello, S; Lorini, R; Maghnie, M; Secco, A; Tinelli, C | 1 |
Dunbar, N; Rivkees, SA; Wilson, TA | 1 |
Loh, JA; Verbalis, JG | 1 |
Byun, DW; Ki, CS; Kim, CH; Kim, SJ; Kim, YJ; Lee, KW; Lee, YK; Lee, YW; Mok, JO; Park, HK; Ryu, JW; Shin, HB; Suh, KI; Yoo, MH | 1 |
Batch, J; Bowling, F; Chitturi, S; Cotterill, AM; Cowley, D; Harris, M; Leong, GM; McGown, I; Thomsett, MJ | 1 |
Mahnke, S; Pogacar, PR; Rivkees, SA | 1 |
Iwasaki, Y; Majzoub, JA; Oiso, Y; Saito, H | 1 |
Ishida, H; Itagaki, E; Katahira, H; Murakawa, S; Ozawa, S; Takizawa, M; Tashiro, T; Ushikawa, K; Yamaguchi, S; Yoshimoto, K | 1 |
Bullmann, C; Grimm, T; Heppner, C; Jockenhövel, F; Kotzka, J; Krone, W; Müller-Wieland, D | 1 |
12 review(s) available for arginine vasopressin and Diabetes Insipidus, Neurogenic
Article | Year |
---|---|
Diagnosis and Management of Central Diabetes Insipidus in Adults.
Topics: Adult; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Humans; Polyuria; Syndrome | 2022 |
Copeptin analysis in endocrine disorders.
Topics: Adult; Arginine; Arginine Vasopressin; Child; Diabetes Insipidus, Neurogenic; Glycopeptides; Humans | 2023 |
Adipsic diabetes insipidus.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Humans; Thirst; Water-Electrolyte Balance | 2021 |
Diagnosis and management of central diabetes insipidus in adults.
Topics: Adult; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Disease Management; Glycopeptides; Humans; Polydipsia, Psychogenic | 2019 |
Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus.
Topics: Animals; Arginine Vasopressin; Cell Death; Diabetes Insipidus, Neurogenic; Endoplasmic Reticulum; Humans; Inclusion Bodies; Mutation; Neurons; Neurophysins; Polyuria; Supraoptic Nucleus | 2010 |
Familial forms of diabetes insipidus: clinical and molecular characteristics.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Humans; Male; Mutation; Phenotype; Polydipsia; Polyuria; Receptors, Vasopressin; Vasopressins | 2011 |
Genetics and diagnosis of central diabetes insipidus.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Humans; Mice; Mice, Knockout; Pregnancy; Pregnancy in Diabetics | 2012 |
Autosomal dominant familial neurohypophyseal diabetes insipidus.
Topics: Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Genes, Dominant; Humans | 2003 |
[Vasopressin secretion and disorders of water metabolism].
Topics: Arginine Vasopressin; Body Water; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Kidney Tubules, Collecting; Osmolar Concentration; Vasopressins | 2006 |
The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics.
Topics: Adult; Antidiuretic Agents; Arginine Vasopressin; Child; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Humans; Infant; Infant Formula; Models, Biological; Osmolar Concentration; Sodium Chloride Symporter Inhibitors; Water-Electrolyte Balance | 2007 |
Disorders of water and salt metabolism associated with pituitary disease.
Topics: Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Humans; Hypernatremia; Hyponatremia; Osmolar Concentration; Water; Water-Electrolyte Imbalance | 2008 |
Management of central diabetes insipidus in infancy with low renal solute load formula and chlorothiazide.
Topics: Arginine Vasopressin; Chlorothiazide; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Infant; Meningitis, Pneumococcal; Osmolar Concentration; Renal Agents; Water-Electrolyte Balance | 2000 |
94 other study(ies) available for arginine vasopressin and Diabetes Insipidus, Neurogenic
Article | Year |
---|---|
A case of central diabetes insipidus due to neurophysin II gene abnormality diagnosed based on a family history of nocturnal enuresis.
Topics: Adult; Arginine Vasopressin; Child; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Female; Humans; Male; Mutation; Neurophysins; Nocturnal Enuresis; Pedigree | 2022 |
Transcriptomic Analysis Reveals that Activating Transcription Factor 3/c-Jun/Lgals3 Axis Is Associated with Central Diabetes Insipidus after Hypothalamic Injury.
Topics: Activating Transcription Factor 3; Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Galectin 3; Hypothalamic Diseases; Male; Transcriptome | 2022 |
Mineralocorticoids induce polyuria by reducing apical aquaporin-2 expression of the kidney in partial vasopressin deficiency.
Topics: Aldosterone; Animals; Aquaporin 2; Arginine Vasopressin; Dexamethasone; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Kidney; Mice; Mineralocorticoids; Polyuria | 2023 |
Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis.
Topics: Anastomosis, Surgical; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Cricetinae; Diabetes Insipidus, Neurogenic; Liver Cirrhosis; Rats; Receptors, Vasopressin | 2023 |
Response to endoplasmic reticulum stress in arginine vasopressin neurons.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Endoplasmic Reticulum Stress; Mice; Neurons; Protein Aggregates; Vasopressins | 2023 |
Testing for Arginine Vasopressin Deficiency.
Topics: Arginine; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Humans | 2023 |
Diagnosis of central diabetes insipidus using a vasopressin radioimmunoassay during hypertonic saline infusion.
Topics: Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Male; Middle Aged; Polyuria; Radioimmunoassay; Saline Solution, Hypertonic; Sodium; Vasopressins | 2020 |
Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
Topics: Aged; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Humans; Hypernatremia; Hypophysitis; Immunotherapy; Liver Neoplasms; Magnetic Resonance Imaging; Male; Nivolumab; Programmed Cell Death 1 Receptor | 2020 |
Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Humans; Mutation; Neurophysins; Pedigree; Polydipsia; Polyuria; Vasopressins | 2021 |
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Female; Humans; Italy; Male; Mutation; Mutation, Missense; Neurophysins; Pedigree | 2021 |
Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene.
Topics: Adult; Arginine Vasopressin; Base Sequence; Cell Differentiation; Cell Line; Cellular Reprogramming; Diabetes Insipidus, Neurogenic; Embryoid Bodies; Genetic Vectors; Humans; Induced Pluripotent Stem Cells; Karyotype; Lentivirus; Male; Transcription Factors | 2017 |
A rat model for pituitary stalk electric lesion-induced central diabetes insipidus: application of 3D printing and further outcome assessments.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Magnetic Resonance Imaging; Male; Pituitary Gland; Printing, Three-Dimensional; Rats, Sprague-Dawley; Severity of Illness Index | 2018 |
Chemical chaperone 4-phenylbutylate reduces mutant protein accumulation in the endoplasmic reticulum of arginine vasopressin neurons in a mouse model for familial neurohypophysial diabetes insipidus.
Topics: Animals; Arginine Vasopressin; Butylamines; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons | 2018 |
Endoplasmic reticulum stress induces apoptosis of arginine vasopressin neurons in central diabetes insipidus via PI3K/Akt pathway.
Topics: Acetylcysteine; Animals; Apoptosis; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum Stress; Hypothalamus; Male; MAP Kinase Signaling System; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats, Sprague-Dawley | 2019 |
Nephrotic syndrome complicated by idiopathic central diabetes insipidus.
Topics: Anti-Inflammatory Agents; Arginine Vasopressin; Child; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Edema; Humans; Male; Nephrotic Syndrome; Prednisolone; Water Deprivation | 2014 |
Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arginine Vasopressin; Autophagy; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Hypothalamus; Inclusion Bodies; Mice; Models, Biological; Neurons; Phagosomes; Phenotype; Protein Aggregates; Sequestosome-1 Protein; Ubiquitinated Proteins; Water Deprivation | 2014 |
Activating transcription factor 6α is required for the vasopressin neuron system to maintain water balance under dehydration in male mice.
Topics: Activating Transcription Factor 6; Animals; Arginine Vasopressin; Dehydration; Diabetes Insipidus, Neurogenic; Endoplasmic Reticulum; Female; Male; Mice; Mice, Knockout; Neurons; Phenotype; Unfolded Protein Response; Water-Electrolyte Balance | 2014 |
Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with vasopressin cell antibodies: description of two cases.
Topics: Adult; Arginine Vasopressin; Autoantibodies; Autoimmune Diseases; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Pregnancy | 2015 |
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.
Topics: Adult; Arginine Vasopressin; Cohort Studies; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Glycopeptides; Humans; Male; Middle Aged; Polydipsia; Polyuria; Sensitivity and Specificity; Syndrome; Water Deprivation | 2015 |
Heterogenous patterns of recovery of thirst in adult patients with adipsic diabetes insipidus.
Topics: Adult; Arginine Vasopressin; Dehydration; Diabetes Insipidus, Neurogenic; Female; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Recovery of Function; Saline Solution, Hypertonic; Thirst; Treatment Outcome; Water-Electrolyte Imbalance | 2016 |
Transient Intraoperative Central Diabetes Insipidus in Moyamoya Patients Undergoing Revascularization Surgery: A Mere Coincidence?
Topics: Administration, Intravenous; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Intraoperative Complications; Male; Middle Aged; Moyamoya Disease; Treatment Outcome; Vascular Surgical Procedures | 2016 |
Identification of five novel arginine vasopressin gene mutations in patients with familial neurohypophyseal diabetes insipidus.
Topics: Adolescent; Adult; Arginine Vasopressin; Child; Child, Preschool; Demography; Diabetes Insipidus, Neurogenic; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Pedigree; Remission Induction; Young Adult | 2016 |
Two novel mutations in seven Czech and Slovak kindreds with familial neurohypophyseal diabetes insipidus-benefit of genetic testing.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Arginine Vasopressin; Base Sequence; Brain; Child; Czech Republic; Diabetes Insipidus, Neurogenic; Family; Female; Genetic Testing; Heterozygote; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Polydipsia; Polyuria; Prevalence; Slovakia; Young Adult | 2016 |
Renal Na+-K+-Cl- cotransporter activity and vasopressin-induced trafficking are lipid raft-dependent.
Topics: Animals; Arginine Vasopressin; Biotinylation; Cell Polarity; Cells, Cultured; Cholesterol; Chromatography, Liquid; Diabetes Insipidus, Neurogenic; Kidney; Loop of Henle; Male; Mass Spectrometry; Membrane Microdomains; Oocytes; Rabbits; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Xenopus | 2008 |
Physiological genomics analysis for central diabetes insipidus.
Topics: Arginine Vasopressin; Chromosomes, Human, Pair 20; Chromosomes, Human, X; Diabetes Insipidus, Neurogenic; Humans; Receptors, Vasopressin | 2008 |
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel mutation in arginine-vasopressin gene in a Brazilian family.
Topics: Adolescent; Adult; Amino Acid Sequence; Arginine Vasopressin; Brazil; Case-Control Studies; Child; Child, Preschool; Diabetes Insipidus, Neurogenic; Female; Genes, Dominant; Heterozygote; Humans; Middle Aged; Mutation; Pedigree; Young Adult | 2008 |
Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus.
Topics: Animals; Arginine Vasopressin; C-Reactive Protein; Cell Death; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Drinking; Eating; Endoplasmic Reticulum; Female; Gene Knock-In Techniques; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nerve Tissue Proteins; Neurons; Polyuria; RNA, Messenger; Supraoptic Nucleus | 2009 |
Autosomal recessive familial neurohypophyseal diabetes insipidus: onset in early infancy.
Topics: Adolescent; Age of Onset; Arabs; Arginine Vasopressin; Base Sequence; Child; Child, Preschool; Diabetes Insipidus, Neurogenic; Family Health; Female; Genes, Recessive; Genetic Linkage; Humans; Hypernatremia; Infant; Male; Microsatellite Repeats; Mutation, Missense; Pedigree | 2010 |
Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease.
Topics: Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Fibrosis; Graves Disease; Humans; Inflammation; Lymphocytes; Male; Methimazole; Middle Aged; Osmolar Concentration; Pituitary Gland, Posterior; Polyuria; Remission Induction; Saline Solution, Hypertonic; Thyroxine; Urine | 2010 |
A patient with essential hypernatremia had good response to desmopressin acetate therapy.
Topics: Adolescent; Antidiuretic Agents; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Drinking; Humans; Hypernatremia; Male; Osmolar Concentration; Severity of Illness Index; Sodium; Treatment Outcome; Water Deprivation | 2010 |
Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin II gene.
Topics: Adult; Arginine Vasopressin; Child, Preschool; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Humans; Male; Neurophysins | 2011 |
Poly(A) tail length of neurohypophysial hormones is shortened under endoplasmic reticulum stress.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Endoplasmic Reticulum Stress; Mice; Oxytocin; Pituitary Hormones, Posterior; Poly A; RNA, Messenger; Supraoptic Nucleus | 2011 |
Severe hyperosmolarity and hypernatremia in an adipsic young woman.
Topics: Adult; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Fluid Therapy; Humans; Hypernatremia; Magnetic Resonance Imaging; Osmolar Concentration; Thirst; Water-Electrolyte Balance | 2011 |
Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene.
Topics: Adult; Arginine Vasopressin; Asian People; Base Sequence; Diabetes Insipidus, Neurogenic; DNA Mutational Analysis; Family; Female; Genes, Dominant; Humans; Male; Molecular Diagnostic Techniques; Mutation, Missense; Neurophysins; Pedigree | 2012 |
Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β.
Topics: Animals; Aquaporin 1; Arginine Vasopressin; Benzoates; Benzylamines; Body Water; Dehydration; Diabetes Insipidus, Neurogenic; Female; Kidney; Liver X Receptors; Mice; Neurons; Orphan Nuclear Receptors; Osmolar Concentration; Paraventricular Hypothalamic Nucleus; Polydipsia; Polyuria; Supraoptic Nucleus; Water-Electrolyte Balance | 2012 |
Late-onset familial neurohypophyseal diabetes insipidus due to a novel mutation in the AVP gene.
Topics: Adolescent; Adult; Arginine Vasopressin; Child; Child, Preschool; Diabetes Insipidus, Neurogenic; Female; Genetic Predisposition to Disease; Humans; Male; Mutation; Sequence Analysis, DNA; Young Adult | 2012 |
A missense mutation in the arginine-vasopressin neurophysin-II gene causes autosomal dominant neurohypophyseal diabetes insipidus in a Chinese family.
Topics: Adolescent; Age of Onset; Arginine Vasopressin; Asian People; Child; Diabetes Insipidus, Neurogenic; Female; Humans; Kidney Concentrating Ability; Male; Middle Aged; Mutation, Missense; Neurophysins; Osmolar Concentration; Pedigree; Saline Solution, Hypertonic; Water Deprivation | 2013 |
Familial central diabetes insipidus detected by nocturnal enuresis.
Topics: Arginine Vasopressin; Brain; Child; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; DNA; Enuresis; Humans; Magnetic Resonance Imaging; Male; Neurophysins; Pedigree; Reverse Transcriptase Polymerase Chain Reaction; Saline Solution, Hypertonic | 2002 |
A signal peptide mutation of the arginine vasopressin gene in monozygotic twins.
Topics: Adult; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Diseases in Twins; Female; Humans; Mutation, Missense; Twins, Monozygotic | 2003 |
Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of
Topics: Adult; Age Factors; Arginine Vasopressin; Autoantibodies; Autoimmune Diseases; Autoimmunity; Diabetes Insipidus, Neurogenic; Female; Fluorescent Antibody Technique, Indirect; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Gland, Posterior; Radiography; Time Factors | 2003 |
Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Genetic Therapy; Genetic Vectors; Homeostasis; Humans; In Situ Hybridization; Infectious Anemia Virus, Equine; Male; Rats; Rats, Brattleboro; Rats, Inbred WKY; Supraoptic Nucleus; Time Factors; Vasoconstrictor Agents; Water | 2003 |
A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus.
Topics: Adolescent; Adult; Aged; Arginine Vasopressin; Base Sequence; Child; Diabetes Insipidus, Neurogenic; Female; Genetic Carrier Screening; Heterozygote; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Neurophysins; Pedigree | 2003 |
[Parenteral depot hormone therapy of diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1957 |
Control of diabetes insipidus by the buccal administration of posterior pituitary powder (pitressin).
Topics: Administration, Buccal; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1957 |
Pitressin toxicity in diabetes insipidus, and the therapeutic superiority of the nasal route for replacement therapy; report of a case.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1957 |
[A case of diabetes insipidus, which appeared refractory to pitressin].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Medical Records; Vasopressins | 1957 |
Pitressino-resistant diabetes insipidus.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1957 |
[New contributions to the clinical manifestations of diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1958 |
Method for demonstrating increased inactivation of pitressin in diabetes insipidus.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1958 |
[Problem of pitressin inactivation of tissue in patients with diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Vasopressins | 1958 |
[Pitressin inactivation in patients with diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Vasopressins | 1958 |
Improvement of diabetes insipidus in hepatitis.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Hepatitis; Vasopressins | 1958 |
[Effect of various forms of posterior pituitary gland extract on kidney function in diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diuresis; Diuretics; Humans; Pituitary Gland, Posterior; Vasopressins | 1958 |
Vasopressin-resistant diabetes insipidus.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Humans; Medical Records; Vasopressins | 1959 |
Inactivation of the antidiuretic activity of vasopressin during pregnancy: a report of a case.
Topics: Alcohols; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Ethanol; Female; Humans; Mental Disorders; Pregnancy; Vasopressins | 1959 |
Hereditary pitressin-resistant diabetes insipidus.
Topics: Arginine Vasopressin; Child; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Infant; Vasopressins | 1959 |
Diminished antidiuretic response to pitressin in diabetes insipidus during the infusion of sodium bicarbonate solution.
Topics: Arginine Vasopressin; Bicarbonates; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Sodium Bicarbonate; Vasopressins | 1961 |
Failure of vasopressin to produce normal urine concentration in patients with diabetes insipidus.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1959 |
Comparative effects of valine-5 angiotensin II amide and pitressin on renal excretory function in diabetes insipidus.
Topics: Angiotensin Amide; Angiotensin II; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Kidney; Valine; Vasopressins | 1962 |
Antidiuretic hormone in the serum of diabetes insipidus patients following injection of novocain.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Procaine; Vasopressins | 1962 |
Pitressin or aldosterone effects in rats with adrenal and neurohypophyseal deficiency.
Topics: Adrenalectomy; Aldosterone; Animals; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Hypophysectomy; Potassium; Rats; Sodium; Vasopressins; Water-Electrolyte Balance | 1962 |
[Vasopressin-resistant diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1963 |
[Diabetes insipidus].
Topics: Arginine Vasopressin; Chlorothiazide; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1962 |
[Diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Vasopressins | 1962 |
[Diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Vasopressins | 1963 |
NASAL SPRAY TREATMENT OF DIABETES INSIPIDUS.
Topics: Aerosols; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Lysine; Nasal Sprays; Vasopressins | 1963 |
[DISORDERS OF WATER-ELECTROLYTE BALANCE].
Topics: Arginine Vasopressin; Calcium; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Hyponatremia; Magnesium; Physiology; Potassium; Sodium; Vasopressins; Water-Electrolyte Balance | 1964 |
DIABETES INSIPIDUS.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Hypertension; Lysine; Obesity; Vasopressins | 1964 |
DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY.
Topics: Aerosols; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Drug Therapy; Humans; Lypressin; Lysine; Nasal Sprays; Pharmaceutical Solutions; Pituitary Hormones, Posterior; Respiratory Therapy; Vasopressins | 1964 |
[POST-TRAUMATIC DIABETES INSIPIDUS AND ITS TREATMENT].
Topics: Adolescent; Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Drug Therapy; Humans; Hydrochlorothiazide; Spironolactone; Vasopressins; Wounds and Injuries | 1964 |
[CHANGES DURING ADRENAL CORTEX HORMONE THERAPY IN RENAL RECEPTIVITY TO ANTIDIURETIC HORMONE IN A CASE OF DIABETES INSIPIDUS].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Drug Therapy; Hepatitis; Humans; Hydrocortisone; Vasopressins | 1964 |
DIABETES INSIPIDUS. DIFFICULTIES IN DIAGNOSIS AND TREATMENT; USE OF SYNTHETIC LYSINE-8 VASOPRESSIN IN PATIENTS INTOLERANT OF OTHER THERAPY.
Topics: Aerosols; Arginine Vasopressin; Biological Transport; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Lypressin; Lysine; Patient Discharge; Vasopressins; Water Deprivation | 1965 |
[EFFECTS OF VASOPRESSIN ON RENAL DIABETES INSIPIDUS].
Topics: Arginine Vasopressin; Child; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Infant; Pharmacology; Vasopressins; Water-Electrolyte Balance | 1965 |
Familial diabetes insipidus; report of one of fourteen cases in four generations.
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Heredity; Humans; Vasopressins | 1955 |
[Pitressin-resistant diabetes insipidus].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Vasopressins | 1961 |
[Effect of antidiuretic hormone and chlorothiazide on the excretion of hyaluronidase in the urine in diabetes insipidus].
Topics: Arginine Vasopressin; Chlorothiazide; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Hyaluronoglucosaminidase; Vasopressins | 1962 |
[Central diabetes insipidus with special reference to late prognosis].
Topics: Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans; Prognosis; Vasopressins | 1961 |
Dominant-negative diabetes insipidus and other endocrinopathies.
Topics: Animals; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Hypothalamus; Mice; Mutation; Neurons; Protein Precursors | 2003 |
A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.
Topics: Animals; Apoptosis; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Drinking; Hypothalamus; Immunohistochemistry; Mice; Mutation; Neurons; Protein Precursors; Urination | 2003 |
Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats.
Topics: Animals; Arginine Vasopressin; Dependovirus; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Hypothalamus, Anterior; Immunohistochemistry; Osmolar Concentration; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Brattleboro | 2003 |
Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis.
Topics: Arginine Vasopressin; Child, Preschool; Diabetes Insipidus, Neurogenic; Female; Genes, Dominant; Humans; Male; Mutation; Pedigree; Sequence Analysis, DNA | 2004 |
Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus.
Topics: Animals; Arginine Vasopressin; Biological Transport; Cell Line, Tumor; Culture Media; Diabetes Insipidus, Neurogenic; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Genes, Dominant; Humans; Linear Models; Microscopy, Confocal; Mutation; Neurophysins; Pituitary Gland, Posterior; Protein Precursors | 2004 |
Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus.
Topics: Arginine Vasopressin; Cells, Cultured; Diabetes Insipidus, Neurogenic; Humans; Microscopy, Confocal; Mutation; Neurophysins; Precipitin Tests; Vasopressins | 2004 |
Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety.
Topics: Adult; Arginine Vasopressin; Base Sequence; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Drinking Behavior; Female; Humans; Molecular Structure; Mutation; Neurophysins; Oxytocin; Pedigree; Polyuria; Protein Precursors; Renal Agents | 2004 |
Acute and fatal hyponatraemia after resection of a craniopharyngioma: a preventable tragedy.
Topics: Adolescent; Antidiuretic Agents; Arginine Vasopressin; Brain Edema; Craniopharyngioma; Diabetes Insipidus, Neurogenic; Diuresis; Fatal Outcome; Female; Humans; Hyponatremia; Pituitary Neoplasms; Postoperative Complications | 2005 |
Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds.
Topics: Adolescent; Adult; Age of Onset; Aged; Arginine Vasopressin; Cell Line, Tumor; Child; Diabetes Insipidus, Neurogenic; Family Health; Female; Gene Expression Regulation; Genotype; Humans; Immunoprecipitation; Male; Microscopy, Confocal; Middle Aged; Mutation; Phenotype; Proteins | 2005 |
Clinical features, diagnosis and molecular studies of familial central diabetes insipidus.
Topics: Arginine Vasopressin; Blood; Diabetes Insipidus, Neurogenic; Exons; Female; Humans; Infant; Mutation; Neurophysins; Osmolar Concentration; Pedigree; Polymorphism, Restriction Fragment Length; Saline Solution, Hypertonic; Sequence Analysis, DNA; Urine; Water Deprivation | 2005 |
A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus.
Topics: Aged, 80 and over; Amino Acid Sequence; Arginine Vasopressin; Base Sequence; Diabetes Insipidus, Neurogenic; Heterozygote; Humans; Hypothalamus; Japan; Magnetic Resonance Imaging; Male; Mutation, Missense; Neurophysins; Pedigree; Pituitary Gland; Protein Precursors; Vasopressins | 2006 |
Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity.
Topics: Adolescent; Arginine Vasopressin; Autoantibodies; Autoimmune Diseases; Case-Control Studies; Chi-Square Distribution; Child; Diabetes Insipidus, Neurogenic; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Pituitary Function Tests; Pituitary Gland; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Pituitary Hormones; Protein Tyrosine Phosphatases; Thyroid Hormones | 2006 |
Mutation of Glu78 of the AVP-NPII gene impairs neurophysin as a carrier protein for arginine vasopressin in a family with neurohypophyseal diabetes insipidus.
Topics: Adolescent; Amino Acid Sequence; Arginine Vasopressin; Base Sequence; Carrier Proteins; Diabetes Insipidus, Neurogenic; DNA Mutational Analysis; Family; Female; Glutamic Acid; Humans; Male; Molecular Sequence Data; Mutation; Neurophysins; Pedigree; Water Deprivation | 2008 |
Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus.
Topics: Arginine Vasopressin; Child; Child, Preschool; Diabetes Insipidus, Neurogenic; Female; Humans; Male; Pituitary Gland, Posterior; Water Deprivation | 2008 |
Effects of various mutations in the neurophysin/glycopeptide portion of the vasopressin gene on vasopressin expression in vitro.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Arginine Vasopressin; Cell Line; Diabetes Insipidus, Neurogenic; Frameshift Mutation; Gene Expression; Glycopeptides; Glycosylation; Humans; Mice; Molecular Sequence Data; Mutation; Mutation, Missense; Neurophysins; Rats; Rats, Brattleboro; Sequence Deletion | 2000 |
Increases in plasma ACTH and cortisol after hypertonic saline infusion in patients with central diabetes insipidus.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Arginine Vasopressin; Blood; Diabetes Insipidus, Neurogenic; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Osmolar Concentration; Renin; Saline Solution, Hypertonic | 2001 |
Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus.
Topics: Adult; Age of Onset; Amino Acid Sequence; Arginine Vasopressin; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 20; Codon, Terminator; Diabetes Insipidus, Neurogenic; Exons; Family; Female; Humans; Mutation; Neurophysins; Pedigree | 2002 |